Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • Alphaアッセイ
  • AlphaLISA CD32a (FcgRIIa, 167F) Binding Kit, 500 Assay Points

AlphaLISA CD32a (FcgRIIa, 167F) Binding Kit, 500 Assay Points

AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA CD32a (FcgRIIa, 167F) Binding Kit, 500 Assay Points
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button

This kit is designed for the detection of binding between FCGR2A (CD32a) (167R) and human IgG Fc fragment using a homogeneous AlphaLISA™ assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics by using competitive binding.

View product information
Feature Specification
Application タンパク質間相互作用
Sample Volume 10 µL

This kit is designed for the detection of binding between FCGR2A (CD32a) (167R) and human IgG Fc fragment using a homogeneous AlphaLISA™ assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics by using competitive binding.

View product information
Product variants
Unit Size: 500 assay points
Part #:
AL3087C
Unit Size: 5,000 assay points
Part #:
AL3087F
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA CD32a (FcgRIIa, 167F) Binding Kit, 500 Assay Points
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead
AlphaLISA CD32a (FcgRIIa, 167F) Binding Kit, 500 Assay Points
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image
Video Play Button
Quick links
  • Variants
  • Video
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Recently viewed
  • Customers also bought
  • Get help

Product information

  • Overview
  • Specifications
  • Video gallery

Overview

This kit is designed for the detection of binding between FCGR2A (CD32a) (167R) and human IgG Fc fragment using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapeutics by using competitive binding.

AlphaLISA features:

  • No-wash steps, no separation steps
  • Ease-of-use: few addition steps, fast assay development
  • Broad range of affinities: detect strong or weak interactions, from pM to mM affinity
  • Distance: measure very large protein or antibody complexes – spanning up to 200 nm or more
  • High avidity: multiple binding sites on each bead enables use of nanomolar concentrations of antibodies or proteins, as well as use of low affinity binders

The Fc-Gamma Receptors (FCGRs) are members of immunoglobulin superfamily and play a critical role in the function of therapeutic antibodies. FCGRs are divided into three classes Fc-Gamma Receptor 1 (CD64), FCGR1; Fc-Gamma Receptor 2 (CD32), FCGR2 and Fc-Gamma receptor 3 (CD16), FCGR3. FCGR2 is expressed as two distinct forms (FCGR2A and FCGR2B) encoded by two different highly homologous genes in a cell type specific manner.

FCGR2 is a low/intermediate affinity receptor for polyvalent immune-complexed IgG. It is involved in phagocytosis, secretion of enzymes and inflammatory mediators, antibody-dependent cellular cytotoxicity (ADCC). FCGR2A delivers an activating signal upon ligand binding. In contrast, FCGR2B delivers an inhibitory signal. FCGR2A contains two amino acid sequences (167R and 167H) that are characteristic of an immunoreceptor tyrosine-based activation motif.

The AlphaLISA detection of FCGR2A and IgG Fc fragment binding uses IgG Fc AlphaLISA™ Acceptor beads to capture the human FCGR2A and Streptavidin-coated Donor beads to capture the biotinylated human FCGR2A. Donor beads and Acceptor beads come into proximity through IgG Fc fragment binding to FCGR2A. Excitation of the Donor beads provokes the release of singlet oxygen that triggers a cascade of energy transfer reactions in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Specifications

Application
Protein-Protein Interaction
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Product Group
Kit
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
FCGR2A
Target Class
Binding Assay
Technology
Alpha
Unit Size
500 assay points

Video gallery

AlphaLISA CD32a (FcgRIIa, 167F) Binding Kit, 500 Assay Points
AlphaLISA CD32a (FcgRIIa, 167F) Binding Kit, 500 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Flyer:-:1
  • Whitepaper:-:1
1-2 of 2 Resources
Whitepaper Icon
Whitepaper
Advancing cancer treatment: The promise of ADCs in oncology and neuro-oncology
Learn more
Flyer Icon
Flyer
Reagent solutions for autoimmunity research.

Advance your autoimmune disease research and benefit from Revvity broad offering of reagent technologies

Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.